论文部分内容阅读
中等剂量阿糖胞苷(1DAra—c 1g/m~2 q12h×6或10)治疗急性非淋巴细胞性白血病7例,收到一定疗效。其毒副反应均为可逆性并可以耐受。血细胞减少期为25.7d。没有发生早期死亡,也没有观察到中枢神经系统的毒副反应。我们认为中等剂量阿糖胞苷比高剂量阿糖胞苷更具优越性。
Moderate dose of cytarabine (1DAra-c 1g / m ~ 2 q12h × 6 or 10) in the treatment of acute non-lymphocytic leukemia in 7 cases, received a certain effect. The toxic side effects are reversible and can be tolerated. Cytopenia for 25.7d. There were no early deaths and no side effects of the central nervous system were observed. We believe that medium dose cytarabine is superior to high dose cytarabine.